- Home
- AMPY vs TLSA Comparison
AMPY vs TLSA Comparison
Compare AMPY & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPY
- TLSA
- Stock Information
- Founded
- AMPY 2011
- TLSA 2013
- Country
- AMPY United States
- TLSA United Kingdom
- Employees
- AMPY N/A
- TLSA N/A
- Industry
- AMPY Oil & Gas Production
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- AMPY Energy
- TLSA Health Care
- Exchange
- AMPY Nasdaq
- TLSA Nasdaq
- Market Cap
- AMPY 214.1M
- TLSA 206.8M
- IPO Year
- AMPY 2011
- TLSA 2000
- Fundamental
- Price
- AMPY $5.38
- TLSA $1.81
- Analyst Decision
- AMPY Strong Buy
- TLSA
- Analyst Count
- AMPY 1
- TLSA 0
- Target Price
- AMPY $11.00
- TLSA N/A
- AVG Volume (30 Days)
- AMPY 1.1M
- TLSA 204.2K
- Earning Date
- AMPY 11-05-2025
- TLSA 01-01-0001
- Dividend Yield
- AMPY N/A
- TLSA N/A
- EPS Growth
- AMPY N/A
- TLSA N/A
- EPS
- AMPY N/A
- TLSA N/A
- Revenue
- AMPY $275,827,100.00
- TLSA N/A
- Revenue This Year
- AMPY N/A
- TLSA N/A
- Revenue Next Year
- AMPY N/A
- TLSA N/A
- P/E Ratio
- AMPY N/A
- TLSA N/A
- Revenue Growth
- AMPY N/A
- TLSA N/A
- 52 Week Low
- AMPY $2.27
- TLSA $0.63
- 52 Week High
- AMPY $6.79
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- AMPY 54.32
- TLSA 49.38
- Support Level
- AMPY $5.17
- TLSA $1.66
- Resistance Level
- AMPY $5.44
- TLSA $1.83
- Average True Range (ATR)
- AMPY 0.33
- TLSA 0.13
- MACD
- AMPY -0.03
- TLSA 0.01
- Stochastic Oscillator
- AMPY 45.36
- TLSA 83.87
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.